VolitionRX Stock
VolitionRX Ltd
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Cameron Reynolds
- Employees
- 57
- Market cap
- $2 M
- IPO
- 02/03/2012
- Web
- volition.com
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases…
VolitionRX stock: price history
1D
-4.5%
1W
-14.8%
1M
-34.5%
6M
-95.0%
YTD
-96.5%
1Y
-98.0%
2Y
-98.8%
5Y
-99.7%
10Y
-99.8%
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~10% stronger price swings than usual
Ask the agents about VolitionRX
Analyst assessment of VolitionRX
0
STRONG BUY
5
BUY
3
HOLD
0
SELL
0
STRONG SELL
8
TOTAL · Buy
As of: 20/04/2026
VolitionRX stock metrics
P/E
-0.05
P/B
-0.05
EV/EBITDA
-0.69
RETURN ON EQUITY
22.8%
NET MARGIN
-1,837.7%
DEBT/EQUITY
-0.37
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
55.3%
FLOAT SHARES
6,655,386
AVG. DAILY VOLUME (30D)
2,648,056
Insider transactions (SEC)
Michel Gaetan
Forterre Gael
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about VolitionRX stock
What does VolitionRX do?
VolitionRX Ltd is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Cameron Reynolds, the company employs around 57 people.
The IPO was on 02/03/2012; the stock trades on AMEX under the ticker VNRX.
What do analysts say about VolitionRX stock?
8 analysts rate the stock, the consensus is Buy (as of 20/04/2026).
This is an external assessment, not a statement by Market Jury.
When does VolitionRX report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 10% stronger than usual.
Does VolitionRX pay a dividend?
No, VolitionRX currently does not pay a dividend.
Which stocks are comparable to VolitionRX?
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Eli Lilly and Company, Johnson & Johnson and AbbVie.
How can I get VolitionRX stock analyzed?
Clicking "Analyze stock" lets five strategies assess VolitionRX against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.